Mass spectrometry data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) showed that primary tumors express YTHDC1 protein at significantly higher levels compared to normal cells (Figure 1B). Here, YTHDC1 is linked to neoplasm.